The PICCOLETO XI A-PREP Study
- Sponsor
- Fondazione Ricerca e Innovazione Cardiovascolare ETS
- Study ID
- NCT07391033
- Status
- Not Yet Recruiting
Notify me when recruiting opens
Save your spot on the interest list for this study. We'll keep your details with this study so our team can follow up when recruiting opens.
Add your contact details and location so we can keep your interest tied to this study.
Conditions
- Coronary Artery Disease
- In-Stent Coronary Artery Restenosis
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Study Details
To compare the angiographic and clinical outcomes of aggressive versus standard balloon preparation during drug-coated balloon (DCB) angioplasty for in-stent restenosis (ISR). The study will evaluate whether more aggressive lesion preparation with cutting/scoring/OPN balloons improves outcomes compared to standard preparation with semi-compliant or non-compliant balloons.
Key Dates
- First listed
- Feb 5, 2026
- Start date
- Jun 1, 2026
- Status verified
- Jan 2026
- Primary completion
- Dec 1, 2027
- Completion
- Jun 1, 2028
Study Design
- Enrollment
- 500 participants (estimated)
Arms
- Arm: Aggressive Lesion PreparationPatients who underwent lesion preparation using cutting/Wolverine balloons, scoring balloons (any brand), and/or OPN balloons prior to DCB angioplasty for ISR.
- Arm: Standard Lesion PreparationPatients who underwent lesion preparation using semi-compliant balloons and/or non-compliant balloons prior to DCB angioplasty for ISR.
Primary Outcome Measure
Major Adverse Cardiovascular Events (MACE) [ Time Frame: 12 months ]
Central Contacts
- Filippo Luca Gurgoglione, MD, PhD+393312048150
- Beatrice Barbano
Related Studies
- Evaluating Cardiovascular Phenotypes Using Induced Pluripotent Stem CellsEnrolling By Invitation · Scripps Translational Science Institute · La Jolla, California
- Product Surveillance RegistryRecruiting · Medtronic · Birmingham, Alabama
- Efficacy and Saftey Study of 99mTc-ECDG in the Evaluation of Coronary Artery Disease (CAD)PHASE2 · Not Yet Recruiting · Cell>Point LLC · Oklahoma City, Oklahoma
- Factors Affect Outcomes in Cardiovascular SurgeryRecruiting · University of California, Davis · Sacramento, California